Therefore, it is critical to consider targeting these pathways during the course of AKI or introducing cardioprotective drugs such as iSGLT2 inhibitors and ACE inhibitors in the immediate aftermath of AKI. The gene discussed is ACE; the disease is acute kidney injury.